GD2-GANGLIOSIDE manufacturers
|
| | GD2-GANGLIOSIDE Basic information |
| Product Name: | GD2-GANGLIOSIDE | | Synonyms: | (2S,4S,5R)-6-((1S,2R)-2-((2S,4S,5R)-2-carboxy-5-ethanamido-4-hydroxy-6-((1R,2R)-1,2,3-trihydroxypropyl)tetrahydro-2H-pyran-2-yloxy)-1,3-dihydroxypropyl)-2-((2S,3R,4R,5S,6R)-2-((2R,3S,4R,5R,6R)-6-((2S,3R,E)-2-dodecanamido-3-hydroxyoctadec-4-enyloxy)-4,5-dihydroxy-2-(hydroxymethyl)tetrahydro-2H-pyran-3-yloxy)-5-((2S,3R,4R,5R,6R)-3-ethanamido-4,5-dihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yloxy)-3-hydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-4-yloxy)-5-ethanamido-4-hydroxytetrahydro-2H-pyran-2-carboxylic acid;Ganglioside GD2 (d18:1/12:0);(2S,4S,5R)-2-((1S,2R)-1-((3R,4S,6S)-6-carboxy-3-ethanamido-6-((2R,3S,4R,5R,6S)-3-((2S,3R,4R,5R,6R)-3-ethanamido-4,5-dihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yloxy)-6-((2R,3S,4R,5R,6R)-6-((2S,3R,E)-2-hexadecanamido-3-hydroxyoctadec-4-enyloxy)-4,5-dihydroxy-2-(hydroxymethyl)tetrahydro-2H-pyran-3-yloxy)-5-hydroxy-2-(hydroxymethyl)tetrahydro-2H-pyran-4-yloxy)-4-hydroxytetrahydro-2H-pyran-2-yl)-1,3-dihydroxypropan-2-yloxy)-5-ethanamido-4-hydroxy-6-((1R,2R)-1,2,3-trihydroxypropyl)tetrahydro-2H-pyran-2-carboxylic acid;Ganglioside GD2 (d18:1/16:0);(2S,4S,5R)-6-((1S,2R)-2-((2S,4S,5R)-2-carboxy-5-ethanamido-4-hydroxy-6-((1R,2R)-1,2,3-trihydroxypropyl)tetrahydro-2H-pyran-2-yloxy)-1,3-dihydroxypropyl)-2-((2S,3R,4R,5S,6R)-2-((2R,3S,4R,5R,6R)-4,5-dihydroxy-6-((2S,3R,E)-3-hydroxy-2-octadecanamidooctadec-4-enyloxy)-2-(hydroxymethyl)tetrahydro-2H-pyran-3-yloxy)-5-((2S,3R,4R,5R,6R)-3-ethanamido-4,5-dihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yloxy)-3-hydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-4-yloxy)-5-ethanamido-4-hydroxytetrahydro-2H-pyran-2-carboxylic acid;Ganglioside GD2 (d18:1/18:0);(2S,4S,5R)-6-((1S,2R)-2-((2S,4S,5R)-2-carboxy-5-ethanamido-4-hydroxy-6-((1R,2R)-1,2,3-trihydroxypropyl)tetrahydro-2H-pyran-2-yloxy)-1,3-dihydroxypropyl)-2-((2S,3R,4R,5S,6R)-2-((2R,3S,4R,5R,6R)-4,5-dihydroxy-6-((2S,3R,E)-3-hydroxy-2-icosanamidooctadec-4-enyloxy)-2-(hydroxymethyl)tetrahydro-2H-pyran-3-yloxy)-5-((2S,3R,4R,5R,6R)-3-ethanamido-4,5-dihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yloxy)-3-hydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-4-yloxy)-5-ethanamido-4-hydroxytetrahydro-2H-pyran-2-carboxylic acid;Ganglioside GD2 (d18:1/20:0) | | CAS: | 65988-71-8 | | MF: | C74H134N4O32 | | MW: | 1591.86336 | | EINECS: | | | Product Categories: | Acidic glycosphingolipids;Cell Signaling and Neuroscience;Gangliosides;GangliosidesGlycan Component Classes;GangliosidesSphingolipids;Glycosphingolipids;Lipids in Cell Signaling | | Mol File: | 65988-71-8.mol |  |
| | GD2-GANGLIOSIDE Chemical Properties |
| storage temp. | −20°C | | form | lyophilized powder |
| WGK Germany | 3 | | HS Code | 29400090 |
| | GD2-GANGLIOSIDE Usage And Synthesis |
| Chemical Properties | lyophilized powder | | Uses | Disialoganglioside-GD2 from bovine brain has been used:
- in the ganglioside- enzyme-linked immunosorbent assay (ELISA)
- in capture ELISA with anti-GD2 antibody (ch14.18)
- as a control to test its effect on reactivating autophagy in primary fibroblasts
| | General Description | Disialoganglioside GD2 is a cell surface-associated glycosphingolipid, which comprises sialic acid moiety and is regarded as a carbohydrate antigen.. It is expressed in the skin melanocytes, central and peripheral nervous system. | | Biochem/physiol Actions | Disialoganglioside GD2 is expressed in neuroblastoma, melanoma and small cell lung cancer. It is an immunotherapeutic target and is also regarded as a tumor-associated antigen. GD2 may favor cell migrationin tumors by promoting cell growth, as well as extracellular matrix component attachment. |
| | GD2-GANGLIOSIDE Preparation Products And Raw materials |
|